help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komatsu, M.
Right arrow Articles by Yamada, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komatsu, M.
Right arrow Articles by Yamada, T.

Endocrinology, Vol 130, 221-228, Copyright © 1992 by Endocrine Society


ARTICLES

Mastoparan-induced hormone release from rat pancreatic islets

M Komatsu, T Aizawa, N Yokokawa, Y Sato, N Okada, N Takasu and T Yamada
Department of Geriatrics, Shinshu University School of Medicine, Nagano- ken, Japan.

Mastoparan, a tetradecapeptide purified from wasp venom, stimulates insulin and glucagon release by rat pancreatic islets in a dose-related manner. In perifusion experiments, mastoparan produces monophasic hormone release, which ceases within 10 min of removal of the peptide. After exposure of the isles to mastoparan, glucose-induced insulin release is clearly retained. In incubation experiments, mastoparan- induced insulin release is greatly blocked by pretreatment of the islets with pertussis toxin or neomycin (inhibitor of phosphoinositide turnover) or by lowering the ambient temperature to 17 C. Pretreatment of the islets with nifedipine (calcium channel blocker), H-7 (inhibitor of A- and C-kinase), somatostatin, or divalent cation-free medium does not affect the response to mastoparan. Pretreatment with parabromophenacylbromide (phospholipase-A2 inhibitor) does not block the response induced by a high concentration of (58 microM) mastoparan. The peptide does not stimulate insulin synthesis during 30 min of incubation. Mastoparan raises the cytosolic free Ca2+ concentration, measured by fura-2, in isolated islet cells at normal (1.9 mM) and very low (6.5 microM) extracellular Ca2+ concentrations. Intravenous administration of mastoparan in rats causes a significant elevation of both insulin and glucagon. Together with the previous data, we conclude that mastoparan stimulates islet hormone release through a temperature- dependent process mediated by pertussis toxin-sensitive GTP-binding protein(s). Activation of phospholipase-C and liberation of intracellular Ca2+ are likely to be coupled to exocytosis. Ca2+ influx through the Ca2+ channel and protein kinase-A and -C appear not to be involved in mastoparan's hormone-releasing action. Phospholipase-A2 may be involved in the hormone release induced by low, but not high, concentrations of the peptide.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Kowluru
Regulatory roles for small G proteins in the pancreatic {beta}-cell: lessons from models of impaired insulin secretion
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E669 - E684.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. H. Amin, H.-Q. Chen, R. Veluthakal, R. B. Silver, J. Li, G. Li, and A. Kowluru
Mastoparan-Induced Insulin Secretion from Insulin-Secreting {beta}TC3 and INS-1 Cells: Evidence for Its Regulation by Rho Subfamily of G Proteins
Endocrinology, October 1, 2003; 144(10): 4508 - 4518.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Nakazaki, A. Crane, M. Hu, V. Seghers, S. Ullrich, L. Aguilar-Bryan, and J. Bryan
cAMP-Activated Protein Kinase-Independent Potentiation of Insulin Secretion by cAMP Is Impaired in SUR1 Null Islets
Diabetes, December 1, 2002; 51(12): 3440 - 3449.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Seghers, M. Nakazaki, F. DeMayo, L. Aguilar-Bryan, and J. Bryan
Sur1 Knockout Mice. A MODEL FOR KATP CHANNEL-INDEPENDENT REGULATION OF INSULIN SECRETION
J. Biol. Chem., March 24, 2000; 275(13): 9270 - 9277.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. M. Jones and S. J. Persaud
Protein Kinases, Protein Phosphorylation, and the Regulation of Insulin Secretion from Pancreatic {beta}-Cells.
Endocr. Rev., August 1, 1998; 19(4): 429 - 461.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Komatsu, M. Noda, and G. W. G. Sharp
Nutrient Augmentation of Ca2+-Dependent and Ca2+-Independent Pathways in Stimulus-Coupling to Insulin Secretion Can Be Distinguished by Their Guanosine Triphosphate Requirements: Studies on Rat Pancreatic Islets
Endocrinology, March 1, 1998; 139(3): 1172 - 1183.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C.-G. Ostenson, S. Zaitsev, P.-O. Berggren, S. Efendic, U. Langel, and T. Bartfai
Galparan: A Powerful Insulin-Releasing Chimeric Peptide Acting at a Novel Site
Endocrinology, August 1, 1997; 138(8): 3308 - 3313.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Yajima, K. Uchino, H. Ito, and S. Kawashima
Mastoparan-Stimulated Prolactin Secretion in Rat Pituitary GH3 Cells Involves Activation of Gq/11 Proteins
Endocrinology, May 1, 1997; 138(5): 1949 - 1958.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Suzuki, T. Aizawa, N. Asanuma, Y. Sato, M. Komatsu, H. Hidaka, N. Itoh, K. Yamauchi, and K. Hashizume
An Early Insulin Intervention Accelerates Pancreatic {beta}-Cell Dysfunction in Young Goto-Kakizaki Rats, a Model of Naturally Occurring Noninsulin-Dependent Diabetes
Endocrinology, March 1, 1997; 138(3): 1106 - 1110.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Asanuma, T. Aizawa, Y. Sato, T. Schermerhorn, M. Komatsu, G. W. G. Sharp, and K. Hashizume
Two Signaling Pathways, from the Upper Glycolytic Flux and from the Mitochondria, Converge to Potentiate Insulin Release
Endocrinology, February 1, 1997; 138(2): 751 - 755.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society